Experiments are proposed to investigate at the molecular level the mechanism of an important biological phenomenon; parental imprinting in mammals. Genetic data and the results of micromanipulation experiments have indicated that portions of the paternal and maternal genomes in mice are functionally non-equivalent, and play complementary roles during development. Thus, the must be differentially modified (""""""""imprinted"""""""") before or during gametogenesis. Available evidence suggests that imprinting could be related to some human genetic diseases and could play a role in the appearance of human embryonic tumors. Our recent results of targeted mutagenesis experiments demonstrated that the gene encoding insulin-like growth factor II (IGF-II) is parentally imprinted. Heterozygous animals carrying a paternally-derived inactivated allele and a maternally-derived intact allele (P-heterozygotes) exhibit a growth-deficiency phenotype. In contrast, when the inactivated gene is maternally derived, heterogous progeny have normal size. There is no apparent phenotypic difference between P-heterozygotes and homozygous mutant animals. Molecular analysis (based on the presence of unique molecular tags that can be used to discriminate between the mutant and wild-type alleles) has indicated that the paternal IGF-II gene is expressed, whereas the maternal allele is practically silent. The gamete-of-origin-dependent """"""""imprint"""""""" switches when the allele passes through the germ line of opposite sex. Because the IGF-II locus is currently the only known model gene system that is subject to imprinting, we propose to use as a resource the available mutant animals and ask a series of questions that should provide insights into the unknown biochemical nature of an """"""""imprint"""""""". Specifically, transgenic animal experiments have been designed to investigate whether an imprinting signal exists on DNA, and, if so, in what location. Moreover, gene transfer experiments using appropriate recipient cultured cells are proposed, which should demonstrate whether the imprint is a covalent DNA modification. If so, additional experiments with cultured cells and whole animals will demonstrate whether an imprint corresponds to methylation of cytosine residues. Finally, other aspects of simple and testable models of imprinting, which are discussed in detail will also be examined.

Agency
National Institute of Health (NIH)
Institute
Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)
Type
Research Project (R01)
Project #
5R01HD028342-02
Application #
3329934
Study Section
Mammalian Genetics Study Section (MGN)
Project Start
1991-08-01
Project End
1996-07-31
Budget Start
1992-08-01
Budget End
1993-07-31
Support Year
2
Fiscal Year
1992
Total Cost
Indirect Cost
Name
Columbia University (N.Y.)
Department
Type
Schools of Medicine
DUNS #
064931884
City
New York
State
NY
Country
United States
Zip Code
10027
Baker, J; Hardy, M P; Zhou, J et al. (1996) Effects of an Igf1 gene null mutation on mouse reproduction. Mol Endocrinol 10:903-18
Ludwig, T; Eggenschwiler, J; Fisher, P et al. (1996) Mouse mutants lacking the type 2 IGF receptor (IGF2R) are rescued from perinatal lethality in Igf2 and Igf1r null backgrounds. Dev Biol 177:517-35
Sell, C; Dumenil, G; Deveaud, C et al. (1994) Effect of a null mutation of the insulin-like growth factor I receptor gene on growth and transformation of mouse embryo fibroblasts. Mol Cell Biol 14:3604-12
Efstratiadis, A (1994) Parental imprinting of autosomal mammalian genes. Curr Opin Genet Dev 4:265-80